Immediate Impact
32 standout
Citing Papers
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
2025 Standout
Lactate and lactylation in cancer
2025 Standout
Works of Michael Devitt being referenced
Phase 1b study of bavdegalutamide, an androgen receptor PROTACdegrader, combined with abiraterone in patients with metastatic prostate cancer.
2022
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Michael Devitt | 40 | 30 | 16 | 62 | 57 | 29 | 136 | |
| Yasir Khan | 61 | 28 | 7 | 28 | 28 | 20 | 200 | |
| Cristina Calderón‐Cabrera | 30 | 12 | 9 | 36 | 39 | 16 | 121 | |
| Yi Lin | 79 | 18 | 12 | 26 | 30 | 18 | 121 | |
| Ana Isabel Teruel | 57 | 22 | 13 | 53 | 59 | 24 | 188 | |
| Kristina Sonnevi | 75 | 22 | 8 | 42 | 88 | 26 | 173 | |
| Waled Bahaj | 50 | 29 | 11 | 51 | 42 | 36 | 183 | |
| Yasuhiro Taniguchi | 20 | 10 | 12 | 38 | 39 | 34 | 213 | |
| Agnieszka Giza | 81 | 34 | 15 | 37 | 121 | 39 | 175 | |
| Shalin Kothari | 33 | 16 | 8 | 31 | 34 | 21 | 99 | |
| Martina Rinelli | 22 | 31 | 40 | 33 | 27 | 20 | 203 |
All Works
Login with ORCID to disown or claim papers
Loading papers...